摘要:
The present invention provides compounds of Formula I: wherein A is selected from the group consisting of; (a), (b), (c) and (d), R 1 is H or F; R 2 is H, —CH 2 OH, C1-C3 alkyl, (e), or (f);; R 3 is H, F, or CN; R 4 is H, F; or CN; and R 5 is H, —CH 3 , or —OCH 3 ; or a pharmaceutically acceptable salt thereof.
摘要翻译:本发明提供了式I的化合物:其中A选自: (a),(b),(c)和(d)中,R 1是H或F; R 2是H,-CH 2 OH,C 1 -C 3烷基,(e)或(f)。 R 3是H,F或CN; R 4是H,F; 或CN; 并且R 5是H,-CH 3或-OCH 3; 或其药学上可接受的盐。
摘要:
The present invention provides compounds of Formula I useful as BACE inhibitors in the treatment of e.g. Alzheimer's disease : wherein A is selected from the group consisting of; of; R 1 is H or F; R 2 is H, -OCH 3 , C1-C3 alkyl,; R 3 is H, -CH 3 , or -OCH 3 ; and R 4 is H or F; or a pharmaceutically acceptable salt thereof.
摘要翻译:本发明提供了可用作BACE抑制剂的式I化合物在治疗例如, 阿尔茨海默病:其中A选自由以下组成的组: 的; R 1是H或F; R 2是H,-OCH 3,C 1 -C 3烷基, R 3是H,-CH 3或-OCH 3; 并且R 4是H或F; 或其药学上可接受的盐。
摘要:
The present invention provides a method of treating a cognitive or neurodegenerative disease, comprising administering to a patient in need of such treatment an effective amount of a compound of the formula I, or a pharmaceutically acceptable salt thereof; in combination with an effective amount of an anti-N3pGlu Abeta monoclonal antibody.